Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Okarma

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Toxicology. Clinical Toxicology|January 1, 1995
Adsorption of charged non-albumin bound drugs by amorphous silicaH Levy, A Dasgupta, A Lin, et al.
AIDS (London, England)|August 1, 1994
Clinical and immunological changes in AIDS patients following adoptive therapy with activated autologous CD8 T cells and interleukin-2 infusionN Klimas, R Patarca, J Walling, et al.
Cancer Research|August 1, 1991
Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancerE M Letessier, D S Heo, T Okarma, et al.
Clinical Immunology and Immunopathology|August 1, 1994
Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivoG G Steger, W C Pierce, R Figlin, et al.
Progress in Clinical and Biological Research|January 1, 1992
The AIS CELLector: a new technology for stem cell purificationT Okarma, J Lebkowski, L Schain, et al.
Cancer Gene Therapy|August 7, 1998
Transgene expression in dendritic cells to induce antigen-specific cytotoxic T cells in healthy donorsR Philip, E Brunette, J Ashton, et al.
Cytotherapy|April 30, 2010
Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipientsJ L Gajewski, S Nimer, R M Saliba, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Toxicology. Clinical Toxicology|January 1, 1995
Adsorption of charged non-albumin bound drugs by amorphous silicaH Levy, A Dasgupta, A Lin, et al.
AIDS (London, England)|August 1, 1994
Clinical and immunological changes in AIDS patients following adoptive therapy with activated autologous CD8 T cells and interleukin-2 infusionN Klimas, R Patarca, J Walling, et al.
Cancer Research|August 1, 1991
Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancerE M Letessier, D S Heo, T Okarma, et al.
Clinical Immunology and Immunopathology|August 1, 1994
Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivoG G Steger, W C Pierce, R Figlin, et al.
Progress in Clinical and Biological Research|January 1, 1992
The AIS CELLector: a new technology for stem cell purificationT Okarma, J Lebkowski, L Schain, et al.
Cancer Gene Therapy|August 7, 1998
Transgene expression in dendritic cells to induce antigen-specific cytotoxic T cells in healthy donorsR Philip, E Brunette, J Ashton, et al.
Cytotherapy|April 30, 2010
Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipientsJ L Gajewski, S Nimer, R M Saliba, et al.
Pageof 1